BRCA1 and cancer: Germline BRCA mutations appear only in 3–5% of unselected BC patients [123], while TNBC with BLP are closely related to BRCA1 mutations, and 80–90% of BRCA1-abnormalities expressing cancers exhibited these phenotypes [124].